Nectar Lifesciences Limited — Board Meeting, 14-11-2024: Outcome of Board Meeting

The Board of Directors of Nectar Lifesciences Ltd. has approved the limited-reviewed unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024. Key highlights include a total income of approximately ₹91,496 Cr for the half-year, with a profit before exceptional items and tax of ₹1,358 Cr. Additionally, the board amended its Materiality of Information Policy. Effective immediately, the heads of units 6 and 7 in Baddi, Himachal Pradesh, will no longer be part of senior management. The meeting occurred from 11:30 A.M. to 1:25 P.M.